These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
400 related articles for article (PubMed ID: 20731243)
1. [Susceptibility of Escherichia coli strains isolated from persons with urinary tract infections in 2007 - 2008 to antimicrobial agents]. Kot B; Wicha J; Zak-Puławska Z Przegl Epidemiol; 2010; 64(2):307-12. PubMed ID: 20731243 [TBL] [Abstract][Full Text] [Related]
2. [Antibiotic resistance rates of extended spectrum beta-lactamase producing Escherichia coli and Klebsiella spp. strains isolated from urinary tract infections in a private hospital]. Akyar I Mikrobiyol Bul; 2008 Oct; 42(4):713-5. PubMed ID: 19149097 [TBL] [Abstract][Full Text] [Related]
3. Extended spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae isolated in a rural hospital. Basak S; Mallick SK; Bose S J Indian Med Assoc; 2009 Dec; 107(12):855-8. PubMed ID: 20509468 [TBL] [Abstract][Full Text] [Related]
4. [Profile of antimicrobial resistance of agents causing urinary tract infections in children]. Ghedira Besbes L; Messaoudi A; Ben Meriem C; Guediche MN Tunis Med; 2004 Mar; 82(3):299-305. PubMed ID: 15382465 [TBL] [Abstract][Full Text] [Related]
5. Susceptibility of Escherichia coli strains isolated from outpatient children with community-acquired urinary tract infection in southern Switzerland. Borsari AG; Bucher B; Brazzola P; Simonetti GD; Dolina M; Bianchetti MG Clin Ther; 2008 Nov; 30(11):2090-5. PubMed ID: 19108796 [TBL] [Abstract][Full Text] [Related]
6. The virulence factors and antibiotic sensitivities of Escherichia coli isolated from recurrent urinary tract infections. Gulsun S; Oguzoglu N; Inan A; Ceran N Saudi Med J; 2005 Nov; 26(11):1755-8. PubMed ID: 16311661 [TBL] [Abstract][Full Text] [Related]
7. Microbiology and Drug Resistance of Pathogens in Patients Hospitalized at the Nephrology Department in the South of Poland. Michno M; Sydor A; Wałaszek M; Sułowicz W Pol J Microbiol; 2018; 67(4):517-524. PubMed ID: 30550238 [TBL] [Abstract][Full Text] [Related]
8. Causative agents and antimicrobial susceptibilities of urinary tract infections in the northwest of Iran. Farajnia S; Alikhani MY; Ghotaslou R; Naghili B; Nakhlband A Int J Infect Dis; 2009 Mar; 13(2):140-4. PubMed ID: 18703368 [TBL] [Abstract][Full Text] [Related]
9. Analysis of 3789 in- and outpatient Escherichia coli isolates from across Canada--results of the CANWARD 2007-2009 study. Lagacé-Wiens PR; Simner PJ; Forward KR; Tailor F; Adam HJ; Decorby M; Karlowsky J; Hoban DJ; Zhanel GG; Diagn Microbiol Infect Dis; 2011 Mar; 69(3):314-9. PubMed ID: 21353959 [TBL] [Abstract][Full Text] [Related]
10. Antibiotic resistance of urinary tract pathogens and evaluation of empirical treatment in Turkish children with urinary tract infections. Yüksel S; Oztürk B; Kavaz A; Ozçakar ZB; Acar B; Güriz H; Aysev D; Ekim M; Yalçinkaya F Int J Antimicrob Agents; 2006 Nov; 28(5):413-6. PubMed ID: 17000085 [TBL] [Abstract][Full Text] [Related]
11. Prevalence and antimicrobial susceptibility of Escherichia coli in outpatient urinary isolates in Izmir, Turkey. Yilmaz N; Agus N; Yurtsever SG; Pullukcu H; Gulay Z; Coskuner A; Kose S; Aydemir S; Gulenc N; Ozgenc O Med Sci Monit; 2009 Nov; 15(11):PI61-5. PubMed ID: 19865064 [TBL] [Abstract][Full Text] [Related]
12. Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in Antananarivo, Madagascar. Randrianirina F; Soares JL; Carod JF; Ratsima E; Thonnier V; Combe P; Grosjean P; Talarmin A J Antimicrob Chemother; 2007 Feb; 59(2):309-12. PubMed ID: 17138569 [TBL] [Abstract][Full Text] [Related]
13. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey. Arslan H; Azap OK; Ergönül O; Timurkaynak F; J Antimicrob Chemother; 2005 Nov; 56(5):914-8. PubMed ID: 16174685 [TBL] [Abstract][Full Text] [Related]
15. In vitro susceptibility pattern of cephalosporin-resistant Gram-negative bacteria. Punpanich W; Tantichattanon W; Wongwatcharapaiboon S; Treeratweeraphong V J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S21-7. PubMed ID: 19255989 [TBL] [Abstract][Full Text] [Related]
16. [In vitro activity of fosfomycin trometamol in the treatment of Escherichia coli related uncomplicated urinary tract infections]. Hoşbul T; Ozyurt M; Baylan O; Bektöre B; Ardiç N; Ceylan S; Erdemoğlu A; Haznedaroğlu T Mikrobiyol Bul; 2009 Oct; 43(4):645-9. PubMed ID: 20084918 [TBL] [Abstract][Full Text] [Related]
17. Increasing prevalence of antibiotic resistance and multi drug resistance among uropathogens. Anandkumar H; Kapur I; Dayanand A J Commun Dis; 2003 Jun; 35(2):102-8. PubMed ID: 15562956 [TBL] [Abstract][Full Text] [Related]
18. Antimicrobial susceptibility of Escherichia coli from community-acquired urinary tract infections in Europe: the ECO·SENS study revisited. Kahlmeter G; Poulsen HO Int J Antimicrob Agents; 2012 Jan; 39(1):45-51. PubMed ID: 22055529 [TBL] [Abstract][Full Text] [Related]
19. Prevalence and antimicrobial resistance patterns of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolated from blood cultures in an Istanbul University Hospital. Koksal F; Ak K; Kucukbasmaci O; Samasti M Chemotherapy; 2009; 55(4):293-7. PubMed ID: 19521075 [TBL] [Abstract][Full Text] [Related]
20. [Antibiotic susceptibility analysis of Enterococcus spp. isolated from urine]. Rudy M; Nowakowska M; Wiechuła B; Zientara M; Radosz-Komoniewska H Przegl Lek; 2004; 61(5):473-6. PubMed ID: 15515808 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]